Differences in Functional and Survival Outcomes Between Patients Receiving Primary Surgery vs Chemoradiation Therapy for Treatment of T1-T2 Oropharyngeal Squamous Cell Carcinoma.
暂无分享,去创建一个
D. Cognetti | A. Luginbuhl | Z. Urdang | A. Agarwal | R. Philips | Joseph M. Curry | Sruti Tekumalla | Dev Amin | Eric V Mastrolonardo | Dylan G Bertoni | Daniel J Campbell | Dev R Amin
[1] S. Ramella,et al. Treatment of oropharyngeal squamous cell carcinoma: is swallowing quality better after TORS or RT? , 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[2] K. Fung,et al. Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial , 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] N. Foster,et al. MC1675, a Phase III Evaluation of De-Escalated Adjuvant Radiation Therapy (DART) vs. Standard Adjuvant Treatment for Human Papillomavirus Associated Oropharyngeal Squamous Cell Carcinoma , 2021, International Journal of Radiation Oncology*Biology*Physics.
[4] W. Mendenhall,et al. De-Intensified (DI) IMPT vs. IMRT(Chemo) for HPV-Associated Oropharynx Cancer (HPV-OPC): Initial Quality of Life (QOL) Results From a Prospective, Multi-Institutional Trial. , 2021, International journal of radiation oncology, biology, physics.
[5] E. Mendez,et al. Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311) , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] Harold Kim,et al. Gastrostomy tube dependence and patient‐reported quality of life outcomes based on type of treatment for human papillomavirus‐associated oropharyngeal cancer: Systematic review and meta‐analysis , 2021, Head & neck.
[7] Christopher U. Jones,et al. Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002) , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] C. Rübe,et al. Randomized phase-III-trial of concurrent chemoradiation for locally advanced head and neck cancer comparing dose reduced radiotherapy with paclitaxel/cisplatin to standard radiotherapy with fluorouracil/cisplatin: The PacCis-trial. , 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[9] A. Garden,et al. Dysphagia After Primary Transoral Robotic Surgery With Neck Dissection vs Nonsurgical Therapy in Patients With Low- to Intermediate-Risk Oropharyngeal Cancer. , 2019, JAMA otolaryngology-- head & neck surgery.
[10] K. Fung,et al. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial. , 2019, The Lancet. Oncology.
[11] C. Lazarus,et al. Prospective instrumental evaluation of swallowing, tongue function, and QOL measures following transoral robotic surgery alone without adjuvant therapy , 2018, Head & neck.
[12] S. Giordano,et al. Two‐year prevalence of dysphagia and related outcomes in head and neck cancer survivors: An updated SEER‐Medicare analysis , 2018, Head & neck.
[13] C. Fakhry,et al. Treatment preferences in human papillomavirus-associated oropharyngeal cancer. , 2018, Future oncology.
[14] D. Hayes,et al. Mature results of a prospective study of deintensified chemoradiotherapy for low‐risk human papillomavirus‐associated oropharyngeal squamous cell carcinoma , 2018, Cancer.
[15] Karina Tukanova,et al. Quality of life in oropharyngeal cancer: a structured review of the literature , 2018, Supportive Care in Cancer.
[16] Songzhu Zhao,et al. Quality of life outcomes of transoral robotic surgery with or without adjuvant therapy for oropharyngeal cancer , 2018, The Laryngoscope.
[17] C. Fuller,et al. Symptom burden as a driver of decisional regret in long‐term oropharyngeal carcinoma survivors , 2017, Head & neck.
[18] Andrew D. Palmer,et al. Long-term Functional and Quality-of-Life Outcomes After Transoral Robotic Surgery in Patients With Oropharyngeal Cancer , 2017, JAMA otolaryngology-- head & neck surgery.
[19] R. Ferris,et al. A prospective evaluation of short‐term dysphagia after transoral robotic surgery for squamous cell carcinoma of the oropharynx , 2017, Cancer.
[20] J. Ridge,et al. Long-term toxicities in 10-year survivors of radiation treatment for head and neck cancer. , 2017, Oral oncology.
[21] L. Johansson,et al. Effect of prophylactic percutaneous endoscopic gastrostomy tube on swallowing in advanced head and neck cancer: A randomized controlled study , 2017, Head & neck.
[22] C. Simon,et al. Meta‐analysis on survival of patients treated with transoral surgery versus radiotherapy for early‐stage squamous cell carcinoma of the oropharynx , 2016, Head & neck.
[23] K. Fung,et al. Transoral robotic surgery vs. radiotherapy for management of oropharyngeal squamous cell carcinoma - A systematic review of the literature. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[24] B. Burkey,et al. Impact of feeding tube choice on severe late dysphagia after definitive chemoradiotherapy for human papillomavirus–negative head and neck cancer , 2015, Head & neck.
[25] James D. Murphy,et al. Aspiration pneumonia after concurrent chemoradiotherapy for head and neck cancer , 2015, Cancer.
[26] M. Daly,et al. Comparison of functional outcomes and quality of life between transoral surgery and definitive chemoradiotherapy for oropharyngeal cancer , 2015, Head & neck.
[27] I. Cook,et al. Persistent dysphagia after head and neck radiotherapy: a common and under-reported complication with significant effect on non-cancer-related mortality. , 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).
[28] Christopher U. Jones,et al. Final results of local-regional control and late toxicity of RTOG 9003: a randomized trial of altered fractionation radiation for locally advanced head and neck cancer. , 2014, International journal of radiation oncology, biology, physics.
[29] F. Feng,et al. Aspiration pneumonia after chemo–intensity‐modulated radiation therapy of oropharyngeal carcinoma and its clinical and dysphagia‐related predictors , 2014, Head & neck.
[30] R. Weber,et al. Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] R. Laborde,et al. Long-term functional and oncologic results of transoral robotic surgery for oropharyngeal squamous cell carcinoma. , 2012, Mayo Clinic proceedings.
[32] G. Weinstein,et al. Transoral robotic surgery for advanced oropharyngeal carcinoma. , 2010, Archives of otolaryngology--head & neck surgery.
[33] K. Ang,et al. Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.
[34] K. Olsen,et al. Transoral robotic surgery for oropharyngeal squamous cell carcinoma: A prospective study of feasibility and functional outcomes , 2009, The Laryngoscope.
[35] A. Garden,et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] A. Cmelak,et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. , 2008, Journal of the National Cancer Institute.
[37] G. Calais,et al. Randomized Trial of Radiation Therapy Versus Concomitant Chemotherapy and Radiation Therapy for Advanced-Stage Oropharynx Carcinoma. , 1999, Journal of the National Cancer Institute.
[38] M. Gönen,et al. Impact of the National Cancer Institute Community Cancer Centers Program on Clinical Trial and Related Activities at a Community Cancer Center in Rural Nebraska. , 2016, Journal of Oncology Practice.